Addition Therapeutics is a Biotech company based in South San Francisco, CA. It has raised $100M in total funding.
Addition Therapeutics funding overview
Addition Therapeutics is a Biotech company based in South San Francisco, CA. Addition Therapeutics has raised $100M in total disclosed funding. That places its disclosed total in the $100M–$250M range. The round record for Addition Therapeutics runs through 2025; nothing later has been disclosed. Investors on record include SR One, Pivotal Life Sciences, Abingworth, Osage University Partners, the Gates Foundation, BEVC. 6 distinct backers are named across the disclosed rounds.
Addition Therapeutics at a glance
Total raised
$100M
Latest round date
December 2025
Industry
Biotech
Headquarters
South San Francisco, CA
Notable investors
SR One, Pivotal Life Sciences, Abingworth, Osage University Partners, the Gates Foundation, BEVC
Frequently asked about Addition Therapeutics funding
How much has Addition Therapeutics raised?
Addition Therapeutics has raised $100M in total disclosed funding across the rounds on record.
Who has invested in Addition Therapeutics?
SR One, Pivotal Life Sciences, Abingworth, Osage University Partners, the Gates Foundation, BEVC are named among the investors backing Addition Therapeutics.
What was the latest Addition Therapeutics funding round?
No round stage has been disclosed for Addition Therapeutics.
Where is Addition Therapeutics based?
Addition Therapeutics is based in South San Francisco, CA.
What sector does Addition Therapeutics operate in?
Addition Therapeutics is tracked under Biotech from South San Francisco, CA, with $100M in disclosed funding.
When did Addition Therapeutics last raise?
The last disclosed Addition Therapeutics round closed in December 2025.
Totals shown for Addition Therapeutics aggregate every disclosed round on file. To see how that compares, browse the Biotech companies in South San Francisco and the investors behind them below.
